Table of Content

1 Market Overview of NSAIDs Drug
1.1 NSAIDs Drug Market Overview
1.1.1 NSAIDs Drug Product Scope
1.1.2 NSAIDs Drug Market Status and Outlook
1.2 Global NSAIDs Drug Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global NSAIDs Drug Market Size by Region (2018-2034)
1.4 Global NSAIDs Drug Historic Market Size by Region (2018-2024)
1.5 Global NSAIDs Drug Market Size Forecast by Region (2024-2034)
1.6 Key Regions, NSAIDs Drug Market Size (2018-2034)
1.6.1 North America NSAIDs Drug Market Size (2018-2034)
1.6.2 Europe NSAIDs Drug Market Size (2018-2034)
1.6.3 Asia-Pacific NSAIDs Drug Market Size (2018-2034)
1.6.4 Latin America NSAIDs Drug Market Size (2018-2034)
1.6.5 Middle East & Africa NSAIDs Drug Market Size (2018-2034)
2 NSAIDs Drug Market by Type
2.1 Introduction
2.1.1 Ibuprofen
2.1.2 Naproxen
2.2 Global NSAIDs Drug Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global NSAIDs Drug Historic Market Size by Type (2018-2024)
2.2.2 Global NSAIDs Drug Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America NSAIDs Drug Revenue Breakdown by Type (2018-2034)
2.3.2 Europe NSAIDs Drug Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America NSAIDs Drug Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Type (2018-2034)
3 NSAIDs Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Drugstores
3.2 Global NSAIDs Drug Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global NSAIDs Drug Historic Market Size by Application (2018-2024)
3.2.2 Global NSAIDs Drug Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America NSAIDs Drug Revenue Breakdown by Application (2018-2034)
3.3.2 Europe NSAIDs Drug Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America NSAIDs Drug Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Application (2018-2034)
4 NSAIDs Drug Competition Analysis by Players
4.1 Global NSAIDs Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2022)
4.3 Date of Key Players Enter into NSAIDs Drug Market
4.4 Global Top Players NSAIDs Drug Headquarters and Area Served
4.5 Key Players NSAIDs Drug Product Solution and Service
4.6 Competitive Status
4.6.1 NSAIDs Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer NSAIDs Drug Products, Services and Solutions
5.1.4 Pfizer NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Pfizer Recent Developments
5.2 GSK
5.2.1 GSK Profile
5.2.2 GSK Main Business
5.2.3 GSK NSAIDs Drug Products, Services and Solutions
5.2.4 GSK NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.2.5 GSK Recent Developments
5.3 Grunenthal
5.3.1 Grunenthal Profile
5.3.2 Grunenthal Main Business
5.3.3 Grunenthal NSAIDs Drug Products, Services and Solutions
5.3.4 Grunenthal NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer NSAIDs Drug Products, Services and Solutions
5.4.4 Bayer NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Bayer Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi NSAIDs Drug Products, Services and Solutions
5.5.4 Sanofi NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Sanofi Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly NSAIDs Drug Products, Services and Solutions
5.6.4 Eli Lilly NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.6.5 Eli Lilly Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca NSAIDs Drug Products, Services and Solutions
5.7.4 AstraZeneca NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.7.5 AstraZeneca Recent Developments
5.8 Endo
5.8.1 Endo Profile
5.8.2 Endo Main Business
5.8.3 Endo NSAIDs Drug Products, Services and Solutions
5.8.4 Endo NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.8.5 Endo Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck NSAIDs Drug Products, Services and Solutions
5.9.4 Merck NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Merck Recent Developments
5.10 Depomed
5.10.1 Depomed Profile
5.10.2 Depomed Main Business
5.10.3 Depomed NSAIDs Drug Products, Services and Solutions
5.10.4 Depomed NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Depomed Recent Developments
5.11 Yunnan Baiyao
5.11.1 Yunnan Baiyao Profile
5.11.2 Yunnan Baiyao Main Business
5.11.3 Yunnan Baiyao NSAIDs Drug Products, Services and Solutions
5.11.4 Yunnan Baiyao NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.11.5 Yunnan Baiyao Recent Developments
5.12 Teva
5.12.1 Teva Profile
5.12.2 Teva Main Business
5.12.3 Teva NSAIDs Drug Products, Services and Solutions
5.12.4 Teva NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.12.5 Teva Recent Developments
5.13 J&J
5.13.1 J&J Profile
5.13.2 J&J Main Business
5.13.3 J&J NSAIDs Drug Products, Services and Solutions
5.13.4 J&J NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.13.5 J&J Recent Developments
5.14 Allergan
5.14.1 Allergan Profile
5.14.2 Allergan Main Business
5.14.3 Allergan NSAIDs Drug Products, Services and Solutions
5.14.4 Allergan NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.14.5 Allergan Recent Developments
5.15 Purdue
5.15.1 Purdue Profile
5.15.2 Purdue Main Business
5.15.3 Purdue NSAIDs Drug Products, Services and Solutions
5.15.4 Purdue NSAIDs Drug Revenue (US$ Million) & (2018-2024)
5.15.5 Purdue Recent Developments
6 North America
6.1 North America NSAIDs Drug Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NSAIDs Drug Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NSAIDs Drug Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NSAIDs Drug Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NSAIDs Drug Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NSAIDs Drug Market Dynamics
11.1 NSAIDs Drug Industry Trends
11.2 NSAIDs Drug Market Drivers
11.3 NSAIDs Drug Market Challenges
11.4 NSAIDs Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market NSAIDs Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global NSAIDs Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global NSAIDs Drug Market Size Share by Region (2018-2024)
Table 4. Global NSAIDs Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global NSAIDs Drug Forecasted Market Size Share by Region (2024-2034)
Table 6. Global NSAIDs Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global NSAIDs Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global NSAIDs Drug Revenue Market Share by Type (2018-2024)
Table 9. Global NSAIDs Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global NSAIDs Drug Revenue Market Share by Type (2024-2034)
Table 11. North America NSAIDs Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America NSAIDs Drug Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe NSAIDs Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe NSAIDs Drug Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific NSAIDs Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific NSAIDs Drug Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America NSAIDs Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America NSAIDs Drug Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa NSAIDs Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa NSAIDs Drug Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global NSAIDs Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global NSAIDs Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global NSAIDs Drug Revenue Market Share by Application (2018-2024)
Table 24. Global NSAIDs Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global NSAIDs Drug Revenue Market Share by Application (2024-2034)
Table 26. North America NSAIDs Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America NSAIDs Drug Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe NSAIDs Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe NSAIDs Drug Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific NSAIDs Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific NSAIDs Drug Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America NSAIDs Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America NSAIDs Drug Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa NSAIDs Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa NSAIDs Drug Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global NSAIDs Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global NSAIDs Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2022)
Table 39. Date of Key Players Enter into NSAIDs Drug Market
Table 40. Global NSAIDs Drug Key Players Headquarters and Area Served
Table 41. NSAIDs Drug Product Solution and Service
Table 42. Global NSAIDs Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer NSAIDs Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in NSAIDs Drug Business of Pfizer (2018-2024)
Table 48. Pfizer Recent Developments
Table 49. GSK Basic Information List
Table 50. GSK Description and Business Overview
Table 51. GSK NSAIDs Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in NSAIDs Drug Business of GSK (2018-2024)
Table 53. GSK Recent Developments
Table 54. Grunenthal Basic Information List
Table 55. Grunenthal Description and Business Overview
Table 56. Grunenthal NSAIDs Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in NSAIDs Drug Business of Grunenthal (2018-2024)
Table 58. Grunenthal Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer NSAIDs Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in NSAIDs Drug Business of Bayer (2018-2024)
Table 63. Bayer Recent Developments
Table 64. Sanofi Basic Information List
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi NSAIDs Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in NSAIDs Drug Business of Sanofi (2018-2024)
Table 68. Sanofi Recent Developments
Table 69. Eli Lilly Basic Information List
Table 70. Eli Lilly Description and Business Overview
Table 71. Eli Lilly NSAIDs Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in NSAIDs Drug Business of Eli Lilly (2018-2024)
Table 73. Eli Lilly Recent Developments
Table 74. AstraZeneca Basic Information List
Table 75. AstraZeneca Description and Business Overview
Table 76. AstraZeneca NSAIDs Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in NSAIDs Drug Business of AstraZeneca (2018-2024)
Table 78. AstraZeneca Recent Developments
Table 79. Endo Basic Information List
Table 80. Endo Description and Business Overview
Table 81. Endo NSAIDs Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in NSAIDs Drug Business of Endo (2018-2024)
Table 83. Endo Recent Developments
Table 84. Merck Basic Information List
Table 85. Merck Description and Business Overview
Table 86. Merck NSAIDs Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in NSAIDs Drug Business of Merck (2018-2024)
Table 88. Merck Recent Developments
Table 89. Depomed Basic Information List
Table 90. Depomed Description and Business Overview
Table 91. Depomed NSAIDs Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in NSAIDs Drug Business of Depomed (2018-2024)
Table 93. Depomed Recent Developments
Table 94. Yunnan Baiyao Basic Information List
Table 95. Yunnan Baiyao Description and Business Overview
Table 96. Yunnan Baiyao NSAIDs Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in NSAIDs Drug Business of Yunnan Baiyao (2018-2024)
Table 98. Yunnan Baiyao Recent Developments
Table 99. Teva Basic Information List
Table 100. Teva Description and Business Overview
Table 101. Teva NSAIDs Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in NSAIDs Drug Business of Teva (2018-2024)
Table 103. Teva Recent Developments
Table 104. J&J Basic Information List
Table 105. J&J Description and Business Overview
Table 106. J&J NSAIDs Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in NSAIDs Drug Business of J&J (2018-2024)
Table 108. J&J Recent Developments
Table 109. Allergan Basic Information List
Table 110. Allergan Description and Business Overview
Table 111. Allergan NSAIDs Drug Products, Services and Solutions
Table 112. Revenue (US$ Million) in NSAIDs Drug Business of Allergan (2018-2024)
Table 113. Allergan Recent Developments
Table 114. Purdue Basic Information List
Table 115. Purdue Description and Business Overview
Table 116. Purdue NSAIDs Drug Products, Services and Solutions
Table 117. Revenue (US$ Million) in NSAIDs Drug Business of Purdue (2018-2024)
Table 118. Purdue Recent Developments
Table 119. North America NSAIDs Drug Market Size by Country (2018-2024) & (US$ Million)
Table 120. North America NSAIDs Drug Market Size by Country (2024-2034) & (US$ Million)
Table 121. Europe NSAIDs Drug Market Size by Country (2018-2024) & (US$ Million)
Table 122. Europe NSAIDs Drug Market Size by Country (2024-2034) & (US$ Million)
Table 123. Asia-Pacific NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 124. Asia-Pacific NSAIDs Drug Market Size by Region (2018-2024) & (US$ Million)
Table 125. Asia-Pacific NSAIDs Drug Market Size by Region (2024-2034) & (US$ Million)
Table 126. Asia-Pacific NSAIDs Drug Market Share by Region (2018-2024)
Table 127. Asia-Pacific NSAIDs Drug Market Share by Region (2024-2034)
Table 128. Latin America NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 129. Latin America NSAIDs Drug Market Size by Country (2018-2024) & (US$ Million)
Table 130. Latin America NSAIDs Drug Market Size by Country (2024-2034) & (US$ Million)
Table 131. Middle East & Africa NSAIDs Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 132. Middle East & Africa NSAIDs Drug Market Size by Country (2018-2024) & (US$ Million)
Table 133. Middle East & Africa NSAIDs Drug Market Size by Country (2024-2034) & (US$ Million)
Table 134. NSAIDs Drug Market Trends
Table 135. NSAIDs Drug Market Drivers
Table 136. NSAIDs Drug Market Challenges
Table 137. NSAIDs Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSAIDs Drug Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global NSAIDs Drug Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global NSAIDs Drug Market Share by Regions: 2022 VS 2034
Figure 4. Global NSAIDs Drug Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America NSAIDs Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe NSAIDs Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific NSAIDs Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America NSAIDs Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa NSAIDs Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Ibuprofen
Figure 11. Global Ibuprofen Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Naproxen
Figure 13. Global Naproxen Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Global NSAIDs Drug Market Size Share by Type: 2022 & 2034
Figure 15. North America NSAIDs Drug Revenue Market Share by Type (2018-2034)
Figure 16. Europe NSAIDs Drug Revenue Market Share by Type (2018-2034)
Figure 17. Asia-Pacific NSAIDs Drug Revenue Market Share by Type (2018-2034)
Figure 18. Latin America NSAIDs Drug Revenue Market Share by Type (2018-2034)
Figure 19. Middle East and Africa NSAIDs Drug Revenue Market Share by Type (2018-2034)
Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 21. Clinics Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Drugstores Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. Global NSAIDs Drug Market Size Share by Application: 2022 & 2034
Figure 24. North America NSAIDs Drug Revenue Market Share by Application (2018-2034)
Figure 25. Europe NSAIDs Drug Revenue Market Share by Application (2018-2034)
Figure 26. Asia-Pacific NSAIDs Drug Revenue Market Share by Application (2018-2034)
Figure 27. Latin America NSAIDs Drug Revenue Market Share by Application (2018-2034)
Figure 28. Middle East and Africa NSAIDs Drug Revenue Market Share by Application (2018-2034)
Figure 29. NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 30. Global Top 5 and Top 10 Players NSAIDs Drug Market Share in 2022
Figure 31. North America NSAIDs Drug Market Share by Country (2018-2034)
Figure 32. U.S. NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 33. Canada NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 34. Germany NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 35. France NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 36. U.K. NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 37. Italy NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 38. Russia NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 39. Nordic Countries NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 40. Asia-Pacific NSAIDs Drug Market Share by Region (2018-2034)
Figure 41. China NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 42. Japan NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 43. South Korea NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 44. Southeast Asia NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 45. India NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 46. Australia NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 47. Latin America NSAIDs Drug Market Share by Country (2018-2034)
Figure 48. Mexico NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 49. Brazil NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa NSAIDs Drug Market Share by Country (2018-2034)
Figure 51. Turkey NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 53. UAE NSAIDs Drug Market Size (2018-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report